These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 5243720

  • 1. Studies on the phagocytic activity of neutrophilic leukocytes.
    Brandt L.
    Scand J Haematol Suppl; 1967; 2():1-126. PubMed ID: 5243720
    [No Abstract] [Full Text] [Related]

  • 2. Observations on the in vitro growth of peripheral leucocytes from patients with myeloproliferative disorders.
    Pegrum GD.
    Br J Haematol; 1966 Nov; 12(6):689-96. PubMed ID: 5224278
    [No Abstract] [Full Text] [Related]

  • 3. Blood histamine in the differential diagnosis of myeloid splenomegaly (osteomyelofibrosis) and other myeloproliferative disorders.
    Gingold N.
    Rev Roum Med; 1974 Nov; 12(1):15-8. PubMed ID: 4533361
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical conference: Histaaminemia in myeloproliferative syndromes].
    Cadiou M, Ruff F, Meunier F, Attalah N, Bernadou A, Zittoun R, Parrot JL, Bousser J.
    Nouv Rev Fr Hematol; 1975 Nov; 15(2):261-9. PubMed ID: 126436
    [No Abstract] [Full Text] [Related]

  • 5. Granulocytic alkaline phosphatase activity in patients with polycythaemia vera.
    Nagy G.
    Acta Med Acad Sci Hung; 1969 Nov; 26(4):325-8. PubMed ID: 5266009
    [No Abstract] [Full Text] [Related]

  • 6. Diagnosis and management of myeloproliferative disorders.
    Laszlo J, Huang AT.
    Curr Probl Cancer; 1977 Jul; 2(1):1-42. PubMed ID: 268266
    [No Abstract] [Full Text] [Related]

  • 7. A study of histamine in myeloproliferative disease.
    Gilbert HS, Warner RR, Wasserman LR.
    Blood; 1966 Dec; 28(6):795-806. PubMed ID: 5959473
    [No Abstract] [Full Text] [Related]

  • 8. [The activity of the alkaline phosphatase of neutrophils in myeloproliferative diseases].
    Vakulenko AD, Shubich MG.
    Ter Arkh; 1966 Feb; 38(2):66-9. PubMed ID: 5235224
    [No Abstract] [Full Text] [Related]

  • 9. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R, Marzetta K, Miglioranza A, Redaelli S, Maino C, Maffiolini A, Gorini M.
    Recenti Prog Med; 2003 Feb; 94(7-8):314-20. PubMed ID: 12868237
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic usefulness of acridine orange in fluorescence microscopy in certain hematological syndromes, particularly in proliferative processes.
    Topolska P, Gürtler-Krawczyńska E.
    Pol Med J; 1968 Feb; 7(2):372-9. PubMed ID: 5241714
    [No Abstract] [Full Text] [Related]

  • 11. The management of elderly patients with myeloproliferative disorders.
    Tura S.
    Hematol Oncol; 1993 Feb; 11 Suppl 1():39-41. PubMed ID: 8486340
    [No Abstract] [Full Text] [Related]

  • 12. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
    Tangün Y.
    Thromb Diath Haemorrh; 1971 Jun 30; 25(2):241-51. PubMed ID: 5284903
    [No Abstract] [Full Text] [Related]

  • 13. Primary polycythaemia. 3. Studies on the significance of the history of the disease and of the treatment for the development of clones in bone marrow cells.
    Visfeldt J, Franzén S, Nielsen A, Tribukait B.
    Acta Pathol Microbiol Scand A; 1973 Mar 30; 81(2):195-203. PubMed ID: 4734062
    [No Abstract] [Full Text] [Related]

  • 14. Phagocytosis in myeloproliferative disorders.
    Corberand J, LaHarrague P, De Larrard B, Nguyen F, Pris J.
    Am J Clin Pathol; 1980 Sep 30; 74(3):301-5. PubMed ID: 6932175
    [Abstract] [Full Text] [Related]

  • 15. [Nosology and diagnosis of myeloproliferative syndrome].
    Zittoun R, Bernadou A, Zittoun J, Fretault J, Bousser J.
    Sem Hop; 1968 Jun 26; 44(31):2079-84. PubMed ID: 4300452
    [No Abstract] [Full Text] [Related]

  • 16. [Primary and secondary thrombocythemia: apropos of 39 cases].
    Bernadou A, Loo H, Prost RJ, Doumenc J, Zittoun R, Bilski-Pasquier G.
    Sem Hop; 1968 Jun 26; 44(31):2092-100. PubMed ID: 4300454
    [No Abstract] [Full Text] [Related]

  • 17. Platelet function and arachidonate metabolism in patients with myeloproliferative disorders.
    Okuma M.
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec 26; 43(6):1139-44. PubMed ID: 6800179
    [No Abstract] [Full Text] [Related]

  • 18. [Granulocyte clearance and granulocyte kinetics in myeloproliferative syndromes].
    Jungi WF, Meuret G, Senn HJ.
    Schweiz Med Wochenschr; 1974 Jan 26; 104(4):133-5. PubMed ID: 4521299
    [No Abstract] [Full Text] [Related]

  • 19. [Chronic myeloproliferative diseases].
    Verh Dtsch Ges Pathol; 1983 Jan 26; 67():214-75. PubMed ID: 6666266
    [No Abstract] [Full Text] [Related]

  • 20. Serum lysozyme and vitamin B 12 binding capacity in myeloproliferative disorders.
    Catovsky D, Galton DA, Griffin C, Hoffbrand AV, Szur L.
    Br J Haematol; 1971 Dec 26; 21(6):661-72. PubMed ID: 5289350
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.